| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051178893 |
| P356 | DOI | 10.2165/00003088-198712010-00003 |
| P698 | PubMed publication ID | 3545615 |
| P2093 | author name string | C K Svensson | |
| P2860 | cites work | Plasma Nicotine Concentrations from Repeated Doses of Nasal Nicotine Solution | Q57477367 |
| A NEW AGE FOR SNUFF? | Q57477418 | ||
| Enzyme Induction in Man caused by Smoking | Q59099024 | ||
| The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration | Q67415893 | ||
| The absorption of nicotine from tobacco snuff through the nasal mucosa | Q68294568 | ||
| Alteration of enzyme activity in rat liver following the acute and chronic administration of nicotine | Q68744798 | ||
| A possible relation between pKa 1 and lipid solubility and the amounts excreted in urine of some tobacco alkaloids given to man | Q68764212 | ||
| Clinical pharmacology of nicotine | Q68876304 | ||
| A substitute for tobacco smoking | Q69574790 | ||
| A controlled trial of nicotine chewing gum in a smoking withdrawal clinic | Q70234363 | ||
| Plasma nicotine levels produced by chewing nicotine gum | Q70248045 | ||
| Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study | Q70390265 | ||
| Nicotine gum to help stop smoking | Q70390270 | ||
| Stimulation of drug and carcinogen metabolism by prolonged oral tobacco consumption | Q70393403 | ||
| Smoking-induced changes in nicotine disposition: application of a new HPLC assay for nicotine and its metabolites | Q70509544 | ||
| Cotinine disposition and effects | Q71064691 | ||
| Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing | Q71704392 | ||
| Smokers of low-yield cigarettes do not consume less nicotine | Q71773884 | ||
| Stimulatory effect of nicotine on the metabolism of meprobamate | Q72907567 | ||
| Absorption of nicotine from various sites | Q79085239 | ||
| Nicotine intake by snuff users | Q24551099 | ||
| Effect of dose on the pharmacokinetics of intravenous nicotine in the rat | Q28316790 | ||
| The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. | Q30498597 | ||
| Transdermal nicotine reduces cigarette craving and nicotine preference | Q34200061 | ||
| Green-tobacco sickness. An illness of tobacco harvesters | Q34211000 | ||
| Rectal drug administration: clinical pharmacokinetic considerations | Q34246983 | ||
| Transdermal administration of nicotine | Q34267700 | ||
| Acute intoxication with nicotine alkaloids and cannabinoids in children from ingestion of cigarettes | Q34272058 | ||
| Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. | Q34278143 | ||
| Disposition kinetics and effects of intravenous nicotine | Q34286683 | ||
| Physiological and pharmacological variability in estimated hepatic blood flow in man. | Q34448582 | ||
| Effect of smoking on theophylline disposition | Q34534103 | ||
| Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects | Q34620868 | ||
| Nicotine and cotinine concentrations in serum and milk of nursing smokers | Q34621728 | ||
| Chewing nicotine gum for 3 months: what happens to plasma nicotine levels? | Q34699923 | ||
| Randomised controlled trial of nicotine chewing-gum | Q34761902 | ||
| Cigarette Smoking: A Dependence on High-Nicotine Boli | Q39221877 | ||
| Role of tobacco smoking in pharmacokinetics | Q39723934 | ||
| Cigarette smoking pharmacokinetics and its relationship to smoking behaviour | Q40191967 | ||
| Smoking and drug metabolism | Q40333041 | ||
| An unusual case of nicotine poisoning | Q40982790 | ||
| Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow | Q41488856 | ||
| Nicotine renal excretion rate influences nicotine intake during cigarette smoking | Q41500117 | ||
| Protective Clothing as a Means of Reducing Nicotine Absorption in Tobacco Harvesters | Q41540517 | ||
| Smoking and pregnancy | Q41580931 | ||
| Effect of food on hepatic blood flow: implications in the "food effect" phenomenon | Q41608956 | ||
| Effects of age and cigarette smoking on propranolol disposition | Q41617556 | ||
| Nasal nicotine solution: a potential aid to giving up smoking? | Q41888866 | ||
| Nicotine pharmacokinetics and its application to intake from smoking | Q42531302 | ||
| The effect of nisoldipine on apparent liver blood flow and effective renal plasma flow | Q43128643 | ||
| The effect of smoking on nicotine metabolism in vivo in man. | Q43498533 | ||
| Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green | Q43885138 | ||
| Commentary: a physiological approach to hepatic drug clearance | Q43996648 | ||
| Tissue distribution of 63H9nicotine in dogs and rhesus monkeys*1 | Q46076453 | ||
| Kinetics of drug action in disease states XI: effect of nicotine on the pharmacodynamics and pharmacokinetics of phenobarbital and ethanol in rats | Q48498220 | ||
| Effects of Increased Liver Metabolism of Nicotine on Its Uptake, Elimination and Toxicity in Mice | Q48892248 | ||
| Effect of hypotension on liver blood flow and lidocaine disposition. | Q51859210 | ||
| Effects of some nicotine metabolites and related compounds on isolated smooth muscle. | Q52753007 | ||
| Exposure of the fetus, neonate, and nursed infant to nicotine and cotinine from maternal smoking. | Q53945428 | ||
| Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow. | Q54464194 | ||
| Clinical use of nicotine chewing-gum. | Q55095869 | ||
| P433 | issue | 1 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 30-40 | |
| P577 | publication date | 1987-01-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Clinical pharmacokinetics of nicotine | |
| P478 | volume | 12 |
| Q73152760 | Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines |
| Q38344189 | Clinical pharmacokinetics of non-opiate abused drugs |
| Q60700081 | Clinically Significant Interactions with Anti-addiction Agents |
| Q90288425 | Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies |
| Q38370130 | Current considerations regarding food addiction |
| Q35159037 | Decreasing smoking behaviour and risk through CYP2A6 inhibition. |
| Q53983052 | Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine. |
| Q37596813 | Future trends in the pharmacological treatment of smoking cessation |
| Q35573329 | Green tobacco sickness. |
| Q68039511 | Increased cotinine elimination and cotinine-N-oxide formation by phenobarbital induction in rat and mouse |
| Q73492503 | Influence of Maternal Nicotine Exposure on Neonatal Rat Lung Structure: Protective Effect of Ascorbic Acid |
| Q36748917 | Interpretation of oral fluid tests for drugs of abuse |
| Q44180785 | Intragastric nicotine protection against 40% ethanol injury in rat stomach. Role of ganglionic stimulation or blockade |
| Q59488334 | Lack of effect of cimetidine on cigarette smoking |
| Q37238140 | Metabolism of nicotine |
| Q73293811 | Nicotine and its metabolite cotinine are mitogenic for human vascular smooth muscle cells |
| Q70175038 | Nicotine metabolism in isolated perfused lung and liver of phenobarbital- and benzoflavone-treated rats |
| Q37301351 | Nicotine's attenuation of body weight involves the perifornical hypothalamus. |
| Q28259520 | Nicotinic plant poisoning |
| Q34749086 | Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications |
| Q49375226 | Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers. |
| Q34448544 | Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users |
| Q37395538 | Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor. |
| Q36576018 | Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive function |
| Q38688263 | Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics |
| Q43067202 | Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment |
| Q38065911 | The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation |
| Q68787576 | The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers |
| Q69426466 | Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study |
| Q36136238 | Translating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond |
| Q39416309 | Vasoactive effects of smoking as mediated through nicotinic stimulation of sympathetic nerve fibers |
Search more.